Osaic Holdings
APRE icon

Osaic Holdings’s Aprea Therapeutics APRE Stock Holding History

Osaic Holdings’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225 Sell
295
-5
-2% -$4 ﹤0.01% 7539
2025
Q4 		$255 Sell
300
-100
-25% -$123 ﹤0.01% 7546
2025
Q3 		$609 Hold
400
– – ﹤0.01% 7496
2025
Q2 		$676 Buy
400
+300
+300% +$511 ﹤0.01% 7281
2025
Q1 		$204 Hold
100
– – ﹤0.01% 7164
2024
Q4 		$329 Sell
100
-50
-33% -$167 ﹤0.01% 7103
2024
Q3 		$413 Buy
150
+50
+50% +$176 ﹤0.01% 7039
2024
Q2 		$407 Sell
100
-200
-67% -$1.03K ﹤0.01% 7032
2024
Q1 		$2.01K Buy
300
+100
+50% +$622 ﹤0.01% 6467
2023
Q4 		$940 Hold
200
– – ﹤0.01% 6773
2023
Q3 		$833 Hold
200
– – ﹤0.01% 6876
2023
Q2 		$630 Hold
200
– – ﹤0.01% 6998
2023
Q1 		$888 Sell
200
-53
-21% -$391 ﹤0.01% 6995
2022
Q4 		$1K Sell
253
-328
-56% -$3.46K ﹤0.01% 6823
2022
Q3 		$8K Hold
581
– – ﹤0.01% 6101
2022
Q2 		$9K Buy
581
+528
+996% +$12.2K ﹤0.01% 6144
2022
Q1 		$2K Hold
53
– – ﹤0.01% 6844
2021
Q4 		$3K Buy
53
+13
+33% +$1.15K ﹤0.01% 6845
2021
Q3 		$4K Hold
40
– – ﹤0.01% 6604
2021
Q2 		$4K Hold
40
– – ﹤0.01% 6454
2021
Q1 		$4K Buy
+40
New +$4.67K ﹤0.01% 6236

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings's APRE Position: Q1 2026 in Review

Osaic Holdings reduced its Aprea Therapeutics (APRE) stake by 1.7% in Q1 2026, selling an estimated $4 and leaving 295 shares worth $225. The position accounts for ﹤0.01% of the portfolio, ranked #7539.

Osaic Holdings first reported a position in APRE in Q1 2021 and has held it in 21 quarters since. The position peaked at $9K in Q2 2022. 22 funds tracked by Wall St. Rank hold APRE as of Q1 2026.

  • Osaic Holdings held 295 shares of Aprea Therapeutics worth $225 as of Q1 2026.
  • Osaic Holdings sold 5 Aprea Therapeutics shares in Q1 2026, an estimated $4.
  • Aprea Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7539 holding.
  • Osaic Holdings first reported a position in Aprea Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Osaic Holdings's Aprea Therapeutics position peaked at $9K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.